A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia

By Feneley M.R.   Dunsmuir W.D.   Pearce J.   Kirby R.S.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 658-663

Elsevier

Access to resources Recommend Favorite

Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial - risk factors and concomitance with hypertension

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 901-906

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

By Roehrborn C.G.   for the ALFUS STUDY GROUP  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

By Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite